Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot
Paul Lacaze(Australian Regenerative Medicine Institute), Ingrid Winship, John Zalcberg(Monash Health), Bronwyn Terrill(Garvan Institute of Medical Research), Abiramy Ragunathan(Camden and Campbelltown Hospitals), Jane Tiller(Monash Health), Jason A. Steen(Monash Health), Nicola Poplawski(Royal Adelaide Hospital), Young Mary-Anne(Garvan Institute of Medical Research), Belinda L. Burns(Government of Western Australia Department of Health), Ari Horton(Monash Children’s Hospital), Rachel Susman(Children's Hospital at Westmead), Dan Belluoccio(Monash University), David Sullivan(Royal Prince Alfred Hospital), Bryony A. Thompson(The University of Queensland), Adam Brotchie(Monash University), Lesley Andrews(Prince of Wales Hospital), Amanda Willis(Garvan Institute of Medical Research), Mathew Wallis(University of Tasmania), Kristen Jean Nowak(The University of Western Australia), John J. McNeil(Monash University), Fiona Bruinsma(Burnet Institute), Lucas A. Mitchell(Garvan Institute of Medical Research), Martin B. Delatycki(Murdoch Children's Research Institute), Tu Nguyen-Dumont(Monash Health), Melissa C. Southey(The University of Melbourne), Gerald F. Watts(The University of Western Australia), Stephen J. Nicholls(Monash Health), David Thomas(Australian Cancer Research Foundation), Zanfina Ademi(Monash Health), Paul James(The Royal Melbourne Hospital), Robert C. Green(Broad Institute), Roger L. Milne(The University of Melbourne), Ranjit Manchanda(Queen Mary University of London), Jing Pang(The University of Western Australia), Judy Kirk(Westmead Hospital), Nicholas Pachter(The University of Western Australia)
Cited by 4
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Cetuximab for the Treatment of Colorectal Cancer
|New England Journal of Medicine|2007|1.8k
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
|The Lancet|2014|750
International nosology of heritable disorders of connective tissue, Berlin, 1986
|American Journal of Medical Genetics|1988|733
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636